氰基丙烯酸酯静脉闭合术后IV型超敏反应
本研究为2012年至2022年在美国四家三级机构开展的回顾性研究,纳入595例接受氰基丙烯酸酯静脉闭合术的患者共881次闭合,T4H发生率为10.4%(92次事件/79例患者,13%)。多因素分析显示年轻年龄(P=0.015)、当前吸烟(P=0.033)及CEAP 3级(P<0.001)和4级(P=0.005)为T4H独立危险因素。
要点
- 595例患者881次氰基丙烯酸酯静脉闭合术中,T4H事件发生率为10.4%(92次),涉及13%的患者(79例)。
- 23%的患者因持续和/或严重症状接受口服类固醇治疗,未发生全身性过敏反应。
- 年轻年龄、当前吸烟及CEAP 3级和4级为T4H独立危险因素。
核心结论
- 这项真实世界多中心研究显示T4H总体发生率为10%。
- 年轻、CEAP 3级和4级患者及吸烟者预示氰基丙烯酸酯T4H风险更高。
研究设计与样本
- 2012年至2022年在美国四家三级机构进行的回顾性研究,纳入接受大隐静脉氰基丙烯酸酯静脉闭合术的患者。
- 共595例患者接受881次氰基丙烯酸酯静脉闭合术,平均年龄66.2 ± 14.9岁,66%为女性。
- 主要终点为术后T4H发生,采用逻辑回归分析预测T4H的危险因素,P值<0.05认为显著。
主要发现
- 共发生92次(10.4%)T4H事件,涉及79例(13%)患者。
- 23%的患者因持续和/或严重症状接受口服类固醇治疗。
- 未发生氰基丙烯酸酯相关全身性过敏反应。
- 多因素分析显示年轻年龄(P=0.015)、当前吸烟状态(P=0.033)、CEAP 3级(P<0.001)和CEAP 4级(P=0.005)为T4H独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonthermal endovenous closure techniques are routinely utilized to treat superficial axial venous reflux. Cyanoacrylate closure is a safe and effective modality implemented for truncal closure. However, an adverse reaction of type IV hypersensitivity (T4H), unique to cyanoacrylate, is a known risk. This study aims to evaluate the real-world incidence of T4H and examine risk factors that may predispose its development. METHODS: A retrospective review between 2012- and 2022 was performed at four tertiary US institutions to examine patients who underwent cyanoacrylate vein closure of their saphenous veins. Patient demographics, comorbidities, CEAP (Clinical [C], Etiological [E], Anatomical [A], and Pathophysiological [P]) classification, and periprocedural outcomes were included. The primary endpoint was development of T4H post procedure. Logistic regression analysis for risk factors predictive of T4H was performed. Variables with a P-value of <0.05 were deemed significant. RESULTS: 595 patients underwent 881 cyanoacrylate venous closures. Mean age was 66.2 ± 14.9, and 66% of patients were female. There were 92 (10.4%) T4H events in 79 (13%) patients. Oral steroids were administered to 23% for persistent and/or severe symptoms. There were no systemic allergic reactions to cyanoacrylate. Multivariate analysis revealed younger age (P = 0.015), active smoking status (P = 0.033), and CEAP 3 (P < 0.001) and 4 (P = 0.005) classifications as independent risk factors associated with development of T4H. CONCLUSIONS: This real-world multicenter study shows the overall incidence of T4H to be 10%. CEAP 3 and 4 patients of younger age and smokers predicted a higher risk of T4H to cyanoacrylate.
引用
- O'Banion LAA, Shao MY, Ali A, et al. Type IV Hypersensitivity Reaction after Cyanoacrylate Venous Closure. Ann Vasc Surg. 2023. PMID: 37301253. doi:10.1016/j.avsg.2023.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。